PharmaVitae: Company Comparator Tool

PharmaVitae: Company Comparator Tool
  • Report price : $ 45 600
  • Publication date : June 2008

Get this Report Now !

PharmaVitae: Company Comparator Tool

Introduction

The Comparator Tool builds from the PharmaVitae profiles of the 50 leading pharma companies. Updated monthly, the tool allows you to compare the 50 players by current and forecast sales to 2012.

Reasons to Purchase

*Compare players by US or global forecast therapy area sales and portfolio breakdown measures to identify winners and losers over the next seven years

*Drill down to the individual drug forecast level for each company, identifying the key drivers behind forecast performance over the next seven years

*Access over 150,000 continuously tracked data points analyzing current and future trends in the pharmaceutical and biotech arenas

RELATED REPORTS

MarketWatch: Biotechnology

MarketWatch: Biotechnology

  • $ 200
  • July 2008
  • 32 pages

Datamonitor's Biotechnology MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Biotechnology industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory a ...

Industries : Pharmaceutical

MarketWatch: CNS

MarketWatch: CNS

  • $ 200
  • July 2008
  • 25 pages

Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in theCN ...

Industries : Pharmaceutical

MarketWatch: Cancer

MarketWatch: Cancer

  • $ 200
  • July 2008
  • 28 pages

Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the major current business issues and events, including R&D news, licensing deals, alliances and joint ventu ...

Industries : Pharmaceutical

MarketWatch: Health Round-up

MarketWatch: Health Round-up

  • $ 400
  • July 2008
  • 48 pages

Datamonitor's MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory an ...

Industries : Pharmaceutical

Commercial and Pipeline Insight: Vaccines for Adults and the Elderly - New blockbuster opportunities ahead

Commercial and Pipeline Insight: Vaccines for Adults and the Elderly - New blockbuster opportunities ahead

  • $ 15 400
  • July 2008
  • 161 pages

IntroductionVaccines have re-emerged as successful revenue generators for Big Pharma, with adults and the elderly now increasingly coming into focus as the next big opportunity in this sector. An aging population, rising disease awareness and new technologies to overcome the scientific hurdles linke ...

Industries : Pharmaceutical

US Enzymes Market

US Enzymes Market

  • $ 4 600
  • June 2008

US demand to grow 6% annually through 2012US demand for enzymes will rise nearly six percent per year to $2.5 billion in 2012. Advances will be led by continued rapid expansion in the fuel ethanol enzyme market, as well as strong growth in the large pharmaceutical and smaller biocatalyst and pulp an ...

Industries : Pharmaceutical

Booming Pharma Sector in India

Booming Pharma Sector in India

  • $ 1 300
  • January 2008

India, a US$ 8.2 Billion pharmaceutical market, represents one of the most emerging pharmaceutical markets in the world. According to the RNCOS latest report “Booming Pharma Sector in India”, in near future, the potential and opportunities within this market will increase by several folds. The m ...

Industries : Pharmaceutical

The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023

The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023

  • $ 2 501
  • June 2008

Visiongain have the pleasure of announcing the latest edition of their industry leading report - The World OTC Pharmaceutical Market, 2008-2023. This edition updates the world OTC market at present and predicts its sales revenues and trends from 2008-2023, including drivers and restraints on the ma ...

Industries : Pharmaceutical

The Pharmaceutical Wholesale and Distribution Industry Outlook and Analysis 2008

The Pharmaceutical Wholesale and Distribution Industry Outlook and Analysis 2008

  • $ 2 501
  • February 2008

The major problem facing the Wholesale & Distribution industry is its low profit margin which is in the region of only 1-2%. However, this market is entering into a crucial period with many key products losing patent protection, facing heavy generic competition. As generics are priced lower than ...

Industries : Pharmaceutical

The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends)

The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends)

  • $ 2 995
  • January 2008

Alzheimer’s Disease is the most common cause of dementia, constituting 60% to 70% of all cases, and the risk with the disease doubles every 5 years after age 65. Incidence of the disease is increasing, and the resulting attention given to Alzheimer's Disease has encouraged development of new treat ...

Industries : Pharmaceutical

24/7 Customer Service

Contact Clare now !

Related industries

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.